
Lithium citrate tribasic tetrahydrate
CAS No. 6080-58-6
Lithium citrate tribasic tetrahydrate ( —— )
产品货号. M15283 CAS No. 6080-58-6
Lithium citrate (Litarex) tetrahydrate 是藤黄果的主要活性成分。Lithium citrate tetrahydrate 可竞争性抑制柠檬酸裂解酶 (ATP citrate lyase) ,并具有减肥效果。Lithium citrate tetrahydrate 有效抑制结石形成并抑制 HIF,具有抗氧化,抗炎和抗肿瘤作用。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
50MG | ¥292 | 有现货 |
![]() ![]() |
100MG | ¥381 | 有现货 |
![]() ![]() |
200MG | ¥551 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Lithium citrate tribasic tetrahydrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lithium citrate (Litarex) tetrahydrate 是藤黄果的主要活性成分。Lithium citrate tetrahydrate 可竞争性抑制柠檬酸裂解酶 (ATP citrate lyase) ,并具有减肥效果。Lithium citrate tetrahydrate 有效抑制结石形成并抑制 HIF,具有抗氧化,抗炎和抗肿瘤作用。
-
产品描述Lithium Citrate is the active component of Lithium which is a drug used in treatment of psychiatric disease. Lithium Citrate has shown the effects on metabolic and signaling pathways in the brain based on the specific clinical condition and disease model. Lithium Citrate has been reported to use as a mood stabilizer when treating bipolar mood disorders (BD) and reduce the risk of self-harm in BD patient. In addition, Lithium Citrate has been found to be the choice drug in treatment of acute manic episodes. Moreover, Lithium Citrate has been revealed to dissolve uric acid crystals in urine obtained from patients with gout. Besides, Lithium Citrate has been exhibited to have some dose-dependent side-effects. The most of the side-effects of Lithium Citrate is the tendency to inhibit the prostatic acid phosphatase enzyme (PAP), which leading to the accumulation of PAP.(In Vitro):Lithium citrate tetrahydrate shows an HIF inhibitory effect compared with the control group in ARPE19 cells and 661W cells. Lithium citrate tetrahydrate can downregulate Hif1a and the downstream genes in ARPE19 cells and 661W cells. Lithium citrate tetrahydrate suppresses HIF-1α protein expression increased by CoCl2 administration in ARPE19 cells and 661W cells.In chicken hepatocytes, Lithium citrate tetrahydrate decreases the accumulation of lipid droplets and accelerated energy metabolism. Lithium citrate tetrahydrate protects the cells from ER stress by increasing the antioxidant status and mitochondrial functions.(In Vivo):Lithium citrate (100-200 mg/kg) tetrahydrate treatment could reduce markers of renal impairment (Blood Urea Nitrogen and serum creatinine). There is significantly less calcium oxalate crystal deposition in mice (male C57BL/6J mice) treated with Lithium citrate tetrahydrate. Lithium citrate tetrahydrate attenuates the oxidative stress induced by calcium oxalate crystallization. Lithium citrate tetrahydrate has inhibitory effects on calcium oxalate-induced inflammatory cytokines, such as MCP-1, IL-1 β, and IL-6. In addition, Lithium citrate tetrahydrate alleviates tubular injury and apoptosis caused by calcium oxalate crystals.The administration of Lithium citrate tetrahydrate can suppress body weight gain and fat accumulation in animals.
-
体外实验Lithium citrate tetrahydrate shows an HIF inhibitory effect compared with the control group in ARPE19 cells and 661W cells. Lithium citrate tetrahydrate can downregulate Hif1a and the downstream genes in ARPE19 cells and 661W cells. Lithium citrate tetrahydrate suppresses HIF-1α protein expression increased by CoCl2 administration in ARPE19 cells and 661W cells.In chicken hepatocytes, Lithium citrate tetrahydrate decreases the accumulation of lipid droplets and accelerated energy metabolism. Lithium citrate tetrahydrate protects the cells from ER stress by increasing the antioxidant status and mitochondrial functions.
-
体内实验Lithium citrate (100-200 mg/kg) tetrahydrate treatment could reduce markers of renal impairment (Blood Urea Nitrogen and serum creatinine). There is significantly less calcium oxalate crystal deposition in mice (male C57BL/6J mice) treated with Lithium citrate tetrahydrate. Lithium citrate tetrahydrate attenuates the oxidative stress induced by calcium oxalate crystallization. Lithium citrate tetrahydrate has inhibitory effects on calcium oxalate-induced inflammatory cytokines, such as MCP-1, IL-1 β, and IL-6. In addition, Lithium citrate tetrahydrate alleviates tubular injury and apoptosis caused by calcium oxalate crystals.The administration of Lithium citrate tetrahydrate can suppress body weight gain and fat accumulation in animals.
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Dehydrogenase
-
受体IMPDH| mGluR3| GSK-3β
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number6080-58-6
-
分子量281.98
-
分子式C6H13Li3O11
-
纯度>98% (HPLC)
-
溶解度Soluble in DMSO
-
SMILES[Li].[Li].[Li].O.O.O.O.OC(=O)CC(O)(CC(O)=O)C(O)=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Oruch R, et al. Eur J Pharmacol. 2014 Jun 30. pii: S0014-2999(14)00493-2
产品手册




关联产品
-
Bipenquinate
Bipenquinate 是一种有效的选择性二氢乳清酸脱氢酶 (DHODH) 抑制剂,IC50 为 20 nM,可阻断嘧啶从头生物合成。
-
Dovitinib Dilactic A...
多韦替尼二乳酸(TKI258二乳酸)是多韦替尼的二乳酸,多韦替尼是一种多靶点RTK抑制剂。
-
hDHODH-IN-3
hDHODH-IN-3 是一种人二氢乳清酸脱氢酶抑制剂,pMIC50 值为 8.6。 hDHODH-IN-3可以抑制麻疹病毒复制。